SCHEMBL7285000

SCHEMBL7285000

CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NC(C=O)CC(=O)O)C(C)C

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 5/20 0.64
SMN1; SMN2 Q16637 1/20 0.51
BACE1 P56817 2/20 0.49
BACE2 Q9Y5Z0 1/20 0.49
CASP3 P42574 2/20 0.49
CASP7 P55210 1/20 0.49
CASP9 P55211 1/20 0.47
REN P00797 1/20 0.46
ACE P12821 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7277740 0.92 CASP1 (0.75) CASP1SMN1; SMN2BACE1BACE2CASP3
SCHEMBL4349143 0.92 CASP1 (0.75) CASP1SMN1; SMN2BACE1BACE2CASP3
SCHEMBL5686946 0.86 CASP1 (0.55) CASP1BACE1BACE2RENACE
SCHEMBL7277278 0.86 SMN1; SMN2 (0.57) CASP1SMN1; SMN2BACE1BACE2CASP3
SCHEMBL8932759 0.84 CASP1 (0.64) CASP1BACE1BACE2CASP3CASP7
SCHEMBL7296578 0.83 CASP1 (0.54) CASP1BACE1BACE2RENACE
SCHEMBL12434601 0.83 CASP1 (0.54) CASP1BACE1BACE2RENACE
SCHEMBL23133187 0.82 CASP1 (0.49) CASP1BACE1BACE2CASP3CASP7
SCHEMBL23133189 0.82 CASP1 (0.49) CASP1BACE1BACE2CASP3CASP7
SCHEMBL20257122 0.82 CASP1 (0.49) CASP1BACE1BACE2CASP3CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0519748-B1 Peptidyl derivatives as inhibitors of interleukin-1B converting enzyme MERCK & CO INC (US) 1998-09-02 EP disclosed
US-5434248-A Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme MERCK & CO., INC. (US) 1995-07-18 US disclosed
EP-0519748-A2 Peptidyl derivatives as inhibitors of interleukin-1B converting enzyme MERCK & CO. INC. (US) 1992-12-23 EP disclosed